Innovative self-care company

MedicaNatumin

MedicaNatumin, formerly Medica Nord, is a Nordic self-care group that develops, markets and sells products that increase people's quality of life and contribute to better everyday health. In addition to products developed in-house, they also in-license certain products. The company acquired Natumin Pharma AB, which is engaged in research and development, in March 2016.

Financials

MEDICANATUMIN

SEKm 2017 2018 2019
Sales 128 209 165
Sales growth (%) 10 63,4 -21
EBITDA 12 62 29
EBITDA margin (%) 9,6 29,7 17,4
EBIT adj 3 54 19
EBIT adj margin (%) 2,4 25,8 11,6
Pretax profit -9 54 19
EPS rep -0,02 0,11 0,04
EPS growth (%) -371,8 805 -65,4
EPS adj 0,01 0,11 0,04
DPS 0 0 0
EV/EBITDA (x) 11,9 5,5 11,1
EV/EBIT adj (x) 47,7 6,4 16,6
P/E (x) -21,5 8,6 24,8
P/E adj (x) 24,6 8,6 24,8
EV/sales (x) 1,2 1,6 1,9
FCF yield (%) -7 10,2 7
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 1,5 -0,3 -1,5